Search terms
Results 1 - 10 of 73 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 8

The COACH program improves lifestyle and biomedical cardiac risk factors Michael V Jelinek1,2, John D Santamaria1,2, David R Thompson3, Margarite J Vale2,4 1St Vincent's Hospital, Melbourne, ...

Heart, PostScript, Michael V Jelinek, John D Santamaria, David R Thompson, Margarite J Vale

Date : 01/11/2012

Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and ...

Heart, Cardiac risk factors and prevention, Julie Redfern, Karice Hyun, Derek P Chew, Carolyn Astley, Clara Chow, Bernadette Aliprandi-Costa, Tegwen Howell, Bridie Carr, Karen Lintern, Isuru ...

Date : 15/08/2014

Despite treatments for secondary prevention, patients with prior myocardial infarction (MI) remain at high risk for recurrent thrombotic events.1 The addition of a P2Y12 receptor antagonist to ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Giulia Magnani, Marc P. Bonaca, Marc S. Sabatine

Date : 01/10/2015 Item size : 188203 bytes

Tokyo University, Tokyo, Japan Aims: Secondary prevention with optimised medical therapy (OMT) is essential for patients who undergo Percutaneous Coronary Intervention (PCI) to improve survival to ...

Date : 17/05/2011 Item size : 33835 bytes

Randomized trials of both invasive and pharmaceutical ACS treatments have confirmed that efficacy extends to the oldest patients,2,3 yet observational studies continue to show that they are less ...

European Heart Journal - Quality of Care and Clinical Outcomes, EDITORIALS, M. Justin Zaman, Chun Shing Kwok, Max O. Bachmann, Mamas A. Mamas, Phyo Kyaw Myint

Date : 01/04/2016 Item size : 165695 bytes

Electrical storm and heart failure worsening in implantable cardiac defibrillator patients Introduction Electrical storm (ES) is a rising challenge in the era of implantable cardiac defibrillator ...

Europace, CLINICAL RESEARCH, Federico Guerra, Marco Flori, Paolo Bonelli, Francesca Patani, Alessandro Capucci

Date : 01/02/2015 Item size : 226707 bytes

Andrew R Chapman, Philip D Adamson, Nicholas L Mills BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK Correspondence to Dr Andrew R Chapman, BHF Centre for Cardiovascular ...

Heart, Review, Andrew R Chapman, Philip D Adamson, Nicholas L Mills

Date : 01/01/2017

Ahmet Temizhan1 Department of Cardiology, Türkiye Yüksek Ýhtisas Hospital, Ankara Although aspirin is effective in the treatment of acute coronary syndrome and in the secondary prevention of ...

Date : 12/01/2017 Item size : 33015 bytes

[...]the benefit of long-term treatment (L-DAPT), continuing beyond the initial 12 months, has been evaluated in a series of trials reported since 2010 and reviewed in several recent ...

European Heart Journal, Editorial, Lars Wallentin

Date : 21/01/2016

Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast The field of percutaneous coronary intervention (PCI) remains extremely active and fruitful, with major advances involving ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 21/01/2016